Skip to main content

Krishnan Krish S's Form 4 filing

Krystal Biotech, Inc. (KRYS) · filed Dec 12, 2023

Accession no.
0001298709-23-000023
Filed
Dec 12, 2023
Trade date
Dec 11, 2023
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions. Open-market sales total $5.28M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krishnan Krish SCIK 0001298709Director, Officer (President and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 11, 2023Common StockSSaleDisposed−4,400$104.41F2−$459,4041,654,938Direct
Dec 11, 2023Common StockSSaleDisposed−6,263$105.50F3−$660,746.51,648,675Direct
Dec 11, 2023Common StockSSaleDisposed−14,237$106.11F4−$1,510,688.071,634,438Direct
Dec 11, 2023Common StockSSaleDisposed−100$107.66−$10,7661,634,338Direct
Dec 11, 2023Common StockSSaleDisposed−2,854$104.26F7−$297,558.041,596,352Indirect
Dec 11, 2023Common StockSSaleDisposed−4,541$105.06F9−$477,077.461,591,811Indirect
Dec 11, 2023Common StockSSaleDisposed−17,505$106.04F10−$1,856,230.21,574,306Indirect
Dec 11, 2023Common StockSSaleDisposed−100$107.66−$10,7661,574,206Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The transaction was executed in multiple trades ranging from $103.9000 to $104.8800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F3

The transaction was executed in multiple trades ranging from $104.9000 to $105.8900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F4

The transaction was executed in multiple trades ranging from $105.9000 to $106.5500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F7

The transaction was executed in multiple trades ranging from $103.5600 to $104.5500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F9

The transaction was executed in multiple trades ranging from $104.5600 to $105.5400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F10

The transaction was executed in multiple trades ranging from $105.5600 to $106.5500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)